logo
Sign in

AGY Stock Price, Chart, Stats & News

Allergy Therapeutics plc
Save

Allergy Therapeutics plc (AGY) does not currently pay a dividend.

354.62M
Market cap
Current P/E
106.38x
Forward P/E

AGY chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut.

Similar securities

Based on sector and market capitalization

Report issue